Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Product revenue, net	$ 16,101	$ 6,837	$ 34,662	$ 9,133
Other revenue	0	53	12	138
Total revenues	16,101	6,890	34,674	9,271
Cost of product revenue	28,946	6,697	54,810	12,209
Gross margin	(12,845)	193	(20,136)	(2,938)
Operating expenses:
Selling, general and administrative	50,385	40,462	96,714	77,929
Research and development	25,162	31,448	50,236	73,035
Total operating expenses	75,547	71,910	146,950	150,964
Gain from sale of priority review voucher, net	0	0	0	92,930
Loss from operations	(88,392)	(71,717)	(167,086)	(60,972)
Interest income	2,837	2,679	5,416	5,507
Interest expense	(5,453)	(3,750)	(10,308)	(8,020)
Other income, net	9,636	9,919	20,802	19,546
Loss before income taxes	(81,372)	(62,869)	(151,176)	(43,939)
Income tax (expense) benefit	(21)	80	(21)	80
Net loss	$ (81,393)	$ (62,789)	$ (151,197)	$ (43,859)
Net loss per share - basic (in dollars per share)	$ (0.42)	$ (0.58)	$ (0.78)	$ (0.41)
Net loss per share - diluted (in dollars per share)	$ (0.42)	$ (0.58)	$ (0.78)	$ (0.41)
Weighted-average number of common shares used in computing net loss per share - basic (in shares)	193,716	108,685	193,433	105,819
Weighted-average number of common shares used in computing net loss per share - diluted (in shares)	193,716	108,685	193,433	105,819
Other comprehensive income (loss):
Total other comprehensive income (loss)	$ (14)	$ 722	$ (327)	$ 1,706
Comprehensive loss	$ (81,407)	$ (62,067)	$ (151,524)	$ (42,153)